Compare BEEP & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BEEP | BHST |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Blank Checks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2M | 104.2M |
| IPO Year | 2021 | N/A |
| Metric | BEEP | BHST |
|---|---|---|
| Price | $3.06 | $4.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.75 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 42.9K | 21.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.20 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,008,000.00 | N/A |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | $2.97 | $55.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.25 | N/A |
| 52 Week Low | $2.50 | $4.27 |
| 52 Week High | $4.67 | $12.80 |
| Indicator | BEEP | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 51.20 | 48.13 |
| Support Level | $3.04 | $4.27 |
| Resistance Level | $3.25 | $5.04 |
| Average True Range (ATR) | 0.20 | 0.27 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 52.29 | 68.83 |
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.